Broad Institute
2447768
217537710
2008-06-06T14:13:05Z
132.183.4.9
/* Facilities */
<!-- Deleted image removed: [[Image:Broad institute logo.gif|250px|right]] -->
The '''Broad Institute''' of [[MIT]] and [[Harvard]] is an American research institute dedicated to the study of [[genomics]] for the biomedical sciences.
==History==
The Broad Institute evolved from a decade of research collaborations among young scientists affiliated with MIT and Harvard.<ref>{{cite web
|title = Broad Institute created: Links Harvard, M.I.T., and others in interdisciplinary initiative in genomics and medicine
|url = http://www.hno.harvard.edu/gazette/2003/07.17/11-broad.html
|publisher = Harvard Gazette
|date = [[2003-07-17]]
|accessdate = 2007-12-25}}</ref>
One cornerstone was the [[Whitehead Institute]] at MIT. Founded in 1982, the Whitehead became a major center for genomics and the [[Human Genome Project]]. As early as 1995, scientists at the Whitehead started pilot projects in genomic medicine, forming an unofficial collaborative network among young scientists interested in genomic approaches to cancer and human genetics.
Another cornerstone was the Institute of Chemistry and Cell Biology established by [[Harvard Medical School]] in 1998 to pursue chemical genetics as an academic discipline.<ref>{{cite web
|url = http://iccb.med.harvard.edu/screening/screening_history.htm
|title = A Brief History of the ICCB-Longwood Screening Facility
|publisher = Harvard Medical School
|accessdate = 2007-12-25}}</ref> Its screening facility was one of the first high-throughput resources opened in an academic setting. It facilitated small molecule screening projects for more than 80 research groups worldwide.
To create a new organization that was open, collaborative, cross-disciplinary and able to organize projects at any scale, planning took place in 2002-2003 among philanthropists [[Eli Broad|Eli and Edythe Broad]], MIT, the Whitehead Institute, Harvard and the Harvard hospitals (the [[Beth Israel Deaconess Medical Center]], [[Brigham and Women's Hospital]], [[Children's Hospital Boston]], the [[Dana-Farber Cancer Institute]] and the [[Massachusetts General Hospital]]).
The Broads made a founding gift of $100 million and the Broad Institute was formally launched in May 2004. In November 2005, the Broads announced an additional $100 million gift to the Institute. <ref>{{cite web
|url = http://www.broad.mit.edu/cgi-bin/news/display_news.cgi?id=202
|title = Broads' Dollars Doubled
|date = [[2005-11-30]]
|publisher = Broad Institute
}}</ref>
''Note: "Broad" rhymes with "toad", not "thawed"; staffers are often seen wearing tee shirts bearing the quip, "Broad as in code."''
==Research programs==
The Broad Institute's scientific research programs include the:
* [[Cancer]] Program
* Program in [[Medical genetics|Medical]] and [[Population Genetics]]
* [[Genome]] Biology and [[Transcriptomics|Cell Circuits]] Program
* [[Chemical biology|Chemical Biology]] Program
* [[Metabolic disease|Metabolic Disease]] Initiative
* [[Infectious Disease]] Initiative
* [[Psychiatry|Psychiatric Disease]] Initiative
* [[Computational Biology]] and [[Bioinformatics]]
==Faculty==
The faculty and staff of the Broad Institute include physicians, geneticists, and molecular, chemical, and computational biologists. The Faculty currently includes six Core Members, whose labs are primarily located within the Broad Institute, and 108 Associate Members, whose primary labs are located at one of the universities or hospitals.
The Core Members of the Broad Institute currently are:
* [[David Altshuler]], a clinical [[endocrinologist]] and [[human genetic]]ist, is director of the Medical and [[Population Genetics]] program. He studies human genetic variation and its application to disease, using tools and information from the Human Genome Project.
* [[Todd Golub]], a physician-researcher, is director of the Cancer program. He applies genomic tools to the classification and study of cancers.
* [[Deborah Hung]] is a chemical biologist and an infectious disease physician who studies the interactions between [[pathogen]]s and their hosts, with the goal of discovering new antibiotic targets.
* [[Eric Lander]] is the director of the Broad Institute. A geneticist, molecular biologist and mathematician, Lander has been a driving force in the development of genomics and a prominent leader of the [[Human Genome Project]].
* [[Aviv Regev]] is a computational biologist with interests in biological networks, gene regulation and evolution.
* [[Stuart Schreiber]] is director of the Chemical Biology program. He has developed systematic ways to explore biology, especially disease biology, using small molecules toward the development of therapeutic drugs.
==Facilities==
The Broad Institute's facilities at 320 Charles Street in [[Cambridge, Massachusetts]], house one of the largest genome [[DNA sequencing|sequencing]] centers in the world. As [[WICGR]] (Whitehead Institute/MIT Center for Genome Research), this facility was the largest contributor of sequence information to the [[Human Genome Project]].
In February 2006, much of The Broad Institute relocated to a new building at 7 Cambridge Center, adjacent to the [[Whitehead Institute for Biomedical Research]].<ref>[http://www.broad.mit.edu/info/visiting.html Map of 320 Charles Street and 7 Cambridge Center, Cambridge, MA]</ref> This seven-story 231,000 square foot building contains office, research laboratory, retail and museum space.
==References==
<references/>
==External links==
* [http://www.broad.mit.edu/index.html Official website of the Broad Institute]
{{MITtemplate}}
[[Category:Genetics or genomics research institutions]]
[[Category:Massachusetts Institute of Technology]]
[[Category:Harvard University]]
[[Category:Biotechnology]]
[[Category:Laboratories]]
[[Category:Harvard Medical School]]
[[Category:Cambridge, Massachusetts]]
[[Category:Research institutes in the United States]]